drugset / Trial / NCT03680456

Postoperative Replacement of Intraoperative Iron Losses

NCT03680456

Phase 4 Completed 134 enrolled Kepler University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

By performing a randomized, blinded placebo controlled exploratory trial we speculate that replacement of perioperative, bleeding-induced iron losses with ferric carboxymaltose immediately after the surgical procedure can replenish iron with increased hemoglobin levels and reduce the amount of pRBCs transfused in the postoperative period (30 days post surgery).

Timeline

Start
2020-03-06
Primary completion
2025-01-31
Completion
2025-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferric carboxymaltose Other / unclassified

Indications